Joint Advisory Committee Will Grapple With Risk-Benefit Profile Of Tysabri For Crohn’s
This article was originally published in The Pink Sheet Daily
Executive Summary
Safety concerns, including the risk of PML, are still relevant considerations, briefing documents state.